Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 248,469 | 238,196 | 109,833 | 44,298 | 98,637 |
| Marketable Securities | 37,986 | 73,442 | 139,123 | 221,412 | 241,299 |
| Receivables | 25,747 | 33,850 | 75,685 | 21,418 | 17,884 |
| TOTAL | $316,109 | $350,250 | $330,650 | $291,906 | $363,112 |
| Non-Current Assets | |||||
| PPE Net | 1,280 | 1,370 | 1,500 | 1,628 | 1,741 |
| Investments And Advances | 0 | 0 | 7,698 | 27,996 | 43,021 |
| Other Non-Current Assets | 12,295 | 12,775 | 13,250 | 13,720 | 14,179 |
| TOTAL | $13,575 | $14,145 | $22,448 | $43,344 | $58,941 |
| Total Assets | $329,684 | $364,395 | $353,098 | $335,250 | $422,053 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,517 | 3,871 | 2,893 | 3,329 | 6,123 |
| Accrued Expenses | 32,065 | 32,674 | 33,171 | 30,197 | 35,952 |
| TOTAL | $41,702 | $38,625 | $38,104 | $35,527 | $44,037 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 275,235 | 288,560 | 344,410 | 344,456 | 343,995 |
| TOTAL | $275,235 | $288,560 | $344,410 | $344,456 | $343,995 |
| Total Liabilities | $316,937 | $327,185 | $382,514 | $379,983 | $388,032 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,101 | 28,748 | 27,688 | 27,997 | 29,381 |
| Common Shares | 29 | 28 | 28 | 28 | 30 |
| Retained earnings | -825,443 | -772,559 | -822,173 | -837,286 | -798,656 |
| Other shareholders' equity | -146 | -24 | 47 | -6 | 161 |
| TOTAL | $12,747 | $37,210 | $-29,416 | $-44,733 | $34,021 |
| Total Liabilities And Equity | $329,684 | $364,395 | $353,098 | $335,250 | $422,053 |